Subscribe
eNewsletter
Ready to get certified?
Free CDCES Coach App
Download
Free Med Pocket Cards
eNewsletter
Free CDCES Coach App
Free Med Pocket Cards
For last week’s practice question, we quizzed participants on low blood sugars and beer. 38% of respondents chose the best answer. We want to clarify and share this important information, … Continue reading Rationale of the Week | Low blood sugars and Beer
There are now five SGLT-2 Inhibitors that are FDA approved for the treatment of diabetes. The latest one is bexagliflozin (Brenzavvy). We created the chart below to summarize the features … Continue reading New “Zavvy” SGLT-2 Inhibitor Approved
Click Here to Test your Knowledge Happy Valentine’s Day, to show our love and appreciation, we are offering 15% off all Online Courses! Our annual Valentine’s sale is our way … Continue reading Question of the Week | February 14, 2023
For last week’s practice question, we quizzed participants on the best action for a safe surgery. 51% of respondents chose the best answer. We want to clarify and share this … Continue reading Rationale of the Week | Safe for Surgery?
Starting in 2023, the Inflation Reduction Act, limits insulin out-of-pocket costs at $35 for a month for each insulin product covered by an individual’s Medicare Part D prescription drug plan or Medicare … Continue reading $35 Cap on Insulin for Medicare Recipients?
JL is 19 and has type 1 diabetes, drinks a “few beers” on the weekends with their college friends. JL uses an insulin pump, but mostly relies of fingerstick checks … Continue reading Question of the Week | Low blood sugars and Beer
For last week’s practice question, we quizzed participants on Diabetes and NASH. 41% of respondents chose the best answer. We want to clarify and share this important information, so you … Continue reading Rationale of the Week | Diabetes and NASH, what is the link?
Happy February February is the month we celebrate love. In my opinion, love is at the center of providing diabetes care and education. We open our hearts as we carefully listen … Continue reading February 2023 eNews | Insulin $35 Cap, New SGLT-2i, Scholarships & Sale